Coronavirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10130701
APP PUB NO 20170216427A1
SERIAL NO

15328179

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE PIRBRIGHT INSTITUTESARI PIERRE BRETT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bickerton, Erica Woking, GB 4 21
Britton, Paul Woking, GB 6 25
Keep, Sarah Woking, GB 2 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 20, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 20, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00